The purpose of this legislation, known as the PREP Repeal Act, is to remove certain legal protections that have been granted to pharmaceutical companies during public health emergencies. Specifically, it aims to repeal sections of the Public Health Service Act that provide liability immunity for products developed in response to pandemics. The lawmakers behind this act believe that these protections have eroded public trust and accountability, and they want to ensure that individuals have the right to seek compensation for any harm caused by these products.